Under the Securities Exchange Act of 1934
(Amendment No. 9)

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

Date of Event Which Requires Filing of this Statement

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this statement, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.  o

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7(b) for other parties to whom copies are to be sent.

The share numbers listed for voting and dispositive power as of a particular date include the number of shares into which options were exercisable or would be exercisable within 60 days of such date.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

April 2, 2018

2

April 2, 2018

3

April 2, 2018

4

The Schedule 13D filed with the Securities and Exchange Commission on December 11, 2000 (the “Initial 13D”) by CFW Partners, the Trust and Mr. Charles F. Willis, IV with respect to the Common Stock, par value $0.01 per share (the “Shares”), issued by Willis Lease Finance Corporation, a Delaware corporation (the “Issuer”), as amended on August 28, 2013, October 1, 2013, July 7, 2015, December 23, 2015, March 23, 2016, May 20, 2016, June 8, 2016 and October 6, 2016 (together with the Initial 13D, the “13D”), is hereby amended to reflect changes in the beneficial ownership information for each of the reporting persons that have occurred as a result of repurchases of Shares by the Issuer.  Capitalized terms not defined herein have the meanings ascribed to them in the 13D.

Item 3.                         Source and Amount of Funds or Other Consideration

Item 3 of the 13D is hereby amended to add the following disclosure following the last paragraph of Item 3 of the 13D:

The Reporting Persons were informed that a total of 294,787 Shares were accepted by the Issuer for repurchase under the Issuer’s Repurchase Program on April 2, 2018.

Due to the resulting decrease in the number of outstanding Shares, the percentage of Shares beneficially owned by the Reporting Persons, changed by one percent (1%) or more from October 4, 2016, the date of the last transaction reported in the 13D.

Item 4.                         Purpose of the Transaction

Item 4 of the 13D is hereby amended to add the following disclosure following the last paragraph of Item 4 of the 13D:

April 2, 2018:  Due to a decrease to the number of outstanding Shares due to a repurchase by the Issuer since the date of the last report, the percentage of Shares beneficially owned by the Reporting Persons changed by one percent (1%) or more from October 4, 2016, the date of the last transaction reported in the 13D.

Item 5.                         Interest in Securities of the Issuer

As disclosed below, each of the Reporting Persons may be deemed to beneficially own (as that term is used in Rule 13d-3) the Shares held by the other Reporting Persons.  Pursuant to Section 13d-4 of the Securities Act of 1933, as amended, each of the Reporting Persons disclaims beneficial ownership of all Shares held by each of the other Reporting Persons.

Items 5(a), 5(b) and 5(c) of the 13D are hereby deleted and replaced with the following:

April 2, 2018

(a)  The Reporting Persons may be deemed to beneficially own (as that term is used in Rule 13d-3), in the aggregate, 2,967,875 Shares, representing approximately 46.70% of the Issuer’s outstanding Shares (based upon the 6,355,447 Shares stated to be outstanding as of April 2, 2018).  Pursuant to Section 13d-4 of the Securities Act of 1933, as amended, each of the Reporting Persons disclaims beneficial ownership of all Shares held by each of the other Reporting Persons.

(b)  For purposes of this statement, as of April 2, 2018:

·                  CFW Partners had shared voting power over and shared dispositive power over the 2,134,148 Shares held by CFW Partners. Mr. Charles Willis had shared voting power over 2,134,148 of such Shares and shared dispositive power over the 2,134,148 Shares held by CFW Partners.  Mr. Austin Willis had shared voting power over 405,488 of such Shares held by CFW Partners.

·                  Mr. Charles Willis had sole voting power over 720,470 Shares. Mr. Charles Willis had sole dispositive power over 468,471 Shares.  Mr. Charles Willis may also have been deemed to have had shared voting power over 109,189 Shares and shared dispositive power with respect to 88,689 Shares held by Mr. Austin Willis.

5

·                  Mr. Austin Willis also had shared voting power over 109,189 Shares and shared dispositive power over 88,689 Shares (pursuant to the Military Durable Power of Attorney dated August 24, 2012 and further discussed in Item 6 of the amendment to the 13D filed on August 28, 2013, Mr. Charles Willis has shared voting power and shared dispositive power with regard to the Shares held by Mr. Austin Willis and the 19% limited partnership interest in CFW Partners held by Mr. Austin Willis).

(c)  The following table sets forth a description of transactions with respect to the Shares effected during the past 60 days by the Reporting Persons:

(1) Return to the Issuer of previously restricted Shares to satisfy withholding tax liability.

(2) Shares transferred to Charles F. Willis V 2016 Trust, Austin Willis Trustee.

(3) Gift of shares from Charles F. Willis to Charlotte Montresor Willis.

(4) Gift of shares from Charles F. Willis, IV to Charles F. Willis V 2016 Trust, Austin Willis Trustee.

(5) Restricted stock grant.

(6) Performance stock grant.

The Reporting Persons may, from time to time and at any time: (i) acquire additional Shares and/or other equity, debt, notes, instruments or other securities (collectively, “Securities”) of the Issuer (or its affiliates) in the open market or otherwise, (ii) dispose of any or all of their Securities in the open market or otherwise, or (iii) engage in any hedging or similar transactions with respect to the Securities.

Item 7.                         Materials to be Filed as Exhibits

1.  Joint Filing Agreement

6

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete, and correct.

7